BURLINGAME, CA, USA (Press Release) - August 19, 2008
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis
Your session will expire in 8 hours requiring you to log in each day to view content.